Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is essential for diagnosing and treating autoimmune cicatricial alopecia early.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Dermoscopy improves accuracy in predicting treatment success for androgenetic alopecia with the Regenera® protocol.

Exclamation-mark hairs and yellow dots indicate alopecia areata, while follicular ostia loss and white scarring indicate lichen planopilaris and discoid lupus erythematosus.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Trichoscopy is a good, quick, non-invasive way to diagnose different types of hair loss.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Early diagnosis and thorough evaluation are crucial for better outcomes in alopecic sarcoidosis.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Interest in new and personalized treatments for hair loss is growing.

Combined microneedling with minoxidil improves hair growth more than minoxidil alone but may cause mild side effects.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Dermoscopy is a useful, low-cost method for diagnosing various types of hair loss disorders known as Cicatricial Alopecia.

A new method using fat tissue cells may help treat hair loss.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Chronic contact eczema may help hair regrowth in alopecia areata by reducing certain immune cell movement.

Accurate diagnosis is crucial for effective treatment of hair loss.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

The new delivery method for finasteride using nanoparticles may improve hair growth without skin issues.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.